TQQQ Target:[$100.00] Target Date:[07/01/2020] ROI:[38%]
NASDAQ-100 INDEX
The NASDAQ-100 Index includes 100 of the largest domestic and international non-financial companies listed on The NASDAQ Stock Market based on market capitalization. The Index reflects companies across major industry groups including computer hardware and software, telecommunications, retail/wholesale trade and biotechnology.
Last week, the Invesco QQQ Trust (QQQ) crossed the $100 billion in assets mark, joining three S&P 500-based ETFs and a total stock market offering from Vanguard.
CFRA rates QQQ as a five-star diversified U.S. equity fund, believing it has a high probability of outperforming in the next nine months due to its low costs and high reward potential, despite slightly elevated risks.
Exposure to the biotech sector which is poised to profit from therapeutics to treat the coronavirus and future pandemics.
Analyst Ratings
Firm Name____________Rating
FactSet ________________A
Ned Davis Research_____BUY
XTF Inc.___________10 out of 10
Morningstar, Inc.*___ 5 out of 5
Zacks Research______Strong Buy
Top Holdings
MSFT
Microsoft Corp
11.92%
AAPL
Apple Inc
11.19%
INTC
Intel Corp
2.97%
CSCO
Cisco Systems Inc
2.11%
NVDA
Nvidia Corp
2.04%
ADBE
Adobe Inc
1.95%
PYPL
Paypal Holdings Inc
1.42%
AVGO
Broadcom Inc
1.19%
TXN
Texas Instruments Inc
1.18%
QCOM
Qualcomm Inc
0.98%
The NASDAQ-100 Index includes 100 of the largest domestic and international non-financial companies listed on The NASDAQ Stock Market based on market capitalization. The Index reflects companies across major industry groups including computer hardware and software, telecommunications, retail/wholesale trade and biotechnology.
Last week, the Invesco QQQ Trust (QQQ) crossed the $100 billion in assets mark, joining three S&P 500-based ETFs and a total stock market offering from Vanguard.
CFRA rates QQQ as a five-star diversified U.S. equity fund, believing it has a high probability of outperforming in the next nine months due to its low costs and high reward potential, despite slightly elevated risks.
Exposure to the biotech sector which is poised to profit from therapeutics to treat the coronavirus and future pandemics.
Analyst Ratings
Firm Name____________Rating
FactSet ________________A
Ned Davis Research_____BUY
XTF Inc.___________10 out of 10
Morningstar, Inc.*___ 5 out of 5
Zacks Research______Strong Buy
Top Holdings
MSFT
Microsoft Corp
11.92%
AAPL
Apple Inc
11.19%
INTC
Intel Corp
2.97%
CSCO
Cisco Systems Inc
2.11%
NVDA
Nvidia Corp
2.04%
ADBE
Adobe Inc
1.95%
PYPL
Paypal Holdings Inc
1.42%
AVGO
Broadcom Inc
1.19%
TXN
Texas Instruments Inc
1.18%
QCOM
Qualcomm Inc
0.98%
Comment:
Remember folks, these are just my ideas, not financial advice!!
Trade closed: target reached
Trade closed: target reached:
Hell of a run!